Please rate your agreement with the following statements. * Please use the scale: 1=Strongly disagree, 2=Disagree, 3=Neutral, 4=Agree, 5=Strongly agree 12345 I can summarize the most recent data on symptomatic treatments for AD. I can summarize the most recent data on symptomatic treatments for AD. - 1 I can summarize the most recent data on symptomatic treatments for AD. - 2 I can summarize the most recent data on symptomatic treatments for AD. - 3 I can summarize the most recent data on symptomatic treatments for AD. - 4 I can summarize the most recent data on symptomatic treatments for AD. - 5 I can summarize the current research on tau imaging. I can summarize the current research on tau imaging. - 1 I can summarize the current research on tau imaging. - 2 I can summarize the current research on tau imaging. - 3 I can summarize the current research on tau imaging. - 4 I can summarize the current research on tau imaging. - 5 Please indicate how frequently you CURRENTLY perform the following clinical practice strategy. * Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me 12345N/A Stay up-to-date on the safety and efficacy of emerging drugs to manage AD. Stay up-to-date on the safety and efficacy of emerging drugs to manage AD. - 1 Stay up-to-date on the safety and efficacy of emerging drugs to manage AD. - 2 Stay up-to-date on the safety and efficacy of emerging drugs to manage AD. - 3 Stay up-to-date on the safety and efficacy of emerging drugs to manage AD. - 4 Stay up-to-date on the safety and efficacy of emerging drugs to manage AD. - 5 Stay up-to-date on the safety and efficacy of emerging drugs to manage AD. - N/A Leave this field blank
